The store will not work correctly when cookies are disabled.
N-(5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl)-4-((trifluoromethyl)thio)benzamide
ID: ALA4789953
PubChem CID: 155235637
Max Phase: Preclinical
Molecular Formula: C17H12F3N3O3S
Molecular Weight: 395.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nnc(NC(=O)c3ccc(SC(F)(F)F)cc3)o2)cc1
Standard InChI: InChI=1S/C17H12F3N3O3S/c1-25-12-6-2-11(3-7-12)15-22-23-16(26-15)21-14(24)10-4-8-13(9-5-10)27-17(18,19)20/h2-9H,1H3,(H,21,23,24)
Standard InChI Key: QJPWTUWZQWKIMQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
15.7825 -8.0316 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.1952 -8.7415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6037 -8.0291 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.6616 -7.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3706 -7.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3654 -8.7343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0706 -9.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7810 -8.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7824 -7.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0772 -7.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6668 -6.6873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9753 -7.9455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4862 -9.1492 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.5277 -7.7971 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2906 -7.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2469 -6.6868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4539 -6.4761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0124 -7.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1940 -7.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7854 -6.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9670 -6.4604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5609 -7.1695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9731 -7.8765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7879 -7.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9028 -9.1538 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.7359 -7.1727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3261 -7.8888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
4 11 2 0
4 12 1 0
13 2 1 0
8 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
14 18 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
18 19 1 0
12 15 1 0
2 25 1 0
22 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 395.36 | Molecular Weight (Monoisotopic): 395.0551 | AlogP: 4.61 | #Rotatable Bonds: 5 |
Polar Surface Area: 77.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.07 | CX Basic pKa: ┄ | CX LogP: 4.57 | CX LogD: 4.56 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.64 | Np Likeness Score: -1.82 |
References
1. Naclerio GA,Abutaleb NS,Li D,Seleem MN,Sintim HO. (2020) Ultrapotent Inhibitor of Clostridioides difficile Growth, Which Suppresses Recurrence In Vivo., 63 (20.0): [PMID:32960605] [10.1021/acs.jmedchem.0c01198] |